Peregrine Pharma (PPHM) Reports In-Line Q3 Loss of 13c/Share

March 9, 2012 4:02 PM EST
Get Alerts PPHM Hot Sheet
Trade PPHM Now!
Join SI Premium – FREE
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) reported Q3 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $3.28 million versus the consensus estimate of $2.12 million.

For earnings history and earnings-related data on Peregrine Pharmaceuticals, Inc. (PPHM) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment